Bioventus
BVS
135 hedge funds and large institutions have $329M invested in Bioventus in 2025 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 40 increasing their positions, 50 reducing their positions, and 24 closing their positions.
8% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 24
3% more capital invested
Capital invested by funds: $320M → $329M (+$8.63M)
1% more funds holding
Funds holding: 134 → 135 (+1)
0.59% more ownership
Funds ownership: 72.92% → 73.51% (+0.59%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
20% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 50
48% less call options, than puts
Call options by funds: $350K | Put options by funds: $669K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KLP
Kent Lake PR
Anasco,
Puerto Rico
|
+$4.51M |
| 2 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$3.68M |
| 3 |
EP
Eversept Partners
New York
|
+$3.01M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$2.2M |
| 5 |
Jane Street
New York
|
+$1.91M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.92M |
| 2 |
Morgan Stanley
New York
|
-$2.84M |
| 3 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$2.67M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$1.87M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$956K |
BVS Hedge Fund Activity: Q3 2025 in Review
135 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q3 2025, worth a combined $329M — up 2.7% from $320M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new BVS positions and 24 closed out — a net gain of 2 holders — while 40 added to existing stakes and 50 trimmed.
The largest buyer was Kent Lake PR, adding an estimated $4.51M. The largest seller was Millennium Management, cutting an estimated $3.92M.
- 135 institutional investors held Bioventus (BVS) as of Q3 2025, up from 134 in Q2 2025.
- Funds reported $329M of Bioventus stock for Q3 2025, up 2.7% quarter-over-quarter.
- 26 funds opened new Bioventus positions in Q3 2025 and 24 closed out, a net change of +2 holders.
- The largest Bioventus buyer in Q3 2025 was Kent Lake PR, an estimated $4.51M added.
- The largest Bioventus seller in Q3 2025 was Millennium Management, an estimated $3.92M sold.
Based on aggregated 13F filings for Q3 2025.